Popular searches: AAPL TSLA NVDA MSFT GOOGL

ORMP Stock Price Prediction 2026

Oramed Pharmaceuticals Inc.

$3.35
$-0.05 (-1.47%)

AI-powered price predictions based on fundamental analysis and growth projections

Last Updated: February 3, 2026

ORMP Price Forecast 2026: Our AI models project that ORMP stock will fall to approximately $3.25 by 2026. This represents a potential 3.0% contraction from the current trading price of $3.35. The overall market sentiment for ORMP is currently neutral, based on a combination of proprietary technical signals and fundamental analysis.

Fundamental Analysis: Trading at a P/E ratio of 3.4, with its most recent quarterly earnings growing by 0.4%. ORMP shows a complex fundamental profile. Our model evaluates these metrics alongside sector peers and historical performance to derive the 2026 price target. If the company exceeds its current growth projections, there may be further upside beyond our base case scenario.

Technical Outlook: The stock is technically in a downtrend phase. The Relative Strength Index (RSI) is currently 55.2, which suggests the stock is trading in a neutral range. Traders should monitor key support and resistance levels closely, as a breakout or breakdown from current price consolidation will be the primary catalyst for the stock reaching the 2026 predicted target.

🎯
AI TRADING RECOMMENDATION
Evaluate position
Key Signals:
  • TTM Squeeze ON for 1 days - volatility compression
  • MACD converging near zero line - potential energy building
  • Volume showing accumulation (CMF: 0.3555)
  • Recent pattern: Doji - Indecision pattern
MACD: Converging | Volume: Accumulation
Fair Value Estimate
+1101.5% Undervalued
Fair Value: $40.25 (Current: $3.35)

Based on PEG ratio analysis, this stock appears undervalued at current levels. The fair value estimate suggests 1101.5% upside potential.

PEG Ratio
0.08
Attractive
Current P/E
3.40
Fair P/E
40.90
Earnings Growth
40.9%
📈

Volume Trend: Accumulation

Institutional Buying Detected - Smart money is accumulating shares

Chaikin Money Flow (CMF): 0.356
Money Flow Index (MFI): 66.5

Positive CMF indicates money flowing into the stock. This bullish signal suggests institutional interest.

Price Targets by Timeframe
AI-based growth projections (not Wall Street analyst targets)
Timeframe Target Price Potential Return
30 Days $3.34 -0.2%
90 Days $3.33 -0.7%
6 Months $3.30 -1.5%
1 Year $3.25 -3.0%

More ORMP Analysis

Why is ORMP Moving? Buy or Sell ORMP? ORMP Full Analysis ORMP Trendline Analysis
ORMP Price Prediction Trendline

Scenario Analysis (1-Year Outlook)

Bull Case
30% Probability
$4.06 (+21.3%)

Best case scenario if strong fundamentals and market conditions align

Base Case
50% Probability
$3.25 (+-3.0%)

Expected scenario based on current growth trajectory

Bear Case
20% Probability
$2.27 (-32.1%)

Downside scenario if market headwinds or disappointing results

Technical Indicators

RSI (14)
55.2
Neutral
MACD Signal
Bearish
Trend
Downtrend
Money Flow (CMF)
0.36

Key Fundamentals

P/E Ratio
3.40
P/S Ratio (TTM)
67.14x
High Premium
Revenue Growth (QoQ)
-1.0%
Earnings Growth (QoQ)
0.4%
Market Cap
$134M
Analyst Target
$3.25
52-Week High
$3.42
52-Week Low
$3.35

Frequently Asked Questions

What is the ORMP stock price prediction for 2026?

Based on our AI analysis, ORMP is predicted to reach $3.25 by 2026, representing a potential 3.0% decrease from the current price of $3.35.

Is ORMP stock a good buy right now?

Our analysis suggests ORMP is a "HOLD" based on current technical and fundamental indicators. With a projected 3.0% downside, investors should consider their risk tolerance and investment horizon.

What is ORMP 52-week high and low?

ORMP has a 52-week high of $3.42 and a 52-week low of $3.35. The stock is currently trading 1.9% below its 52-week high.

What is the technical analysis for ORMP?

ORMP is currently in a downtrend trend. The RSI of 55.2 indicates the stock is trading in neutral territory. Traders should monitor support and resistance levels for potential entry points.

Investment Disclaimer: These price predictions are generated using AI models and historical data. They are not financial advice and should not be the sole basis for investment decisions. Past performance does not guarantee future results. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.
Buy or Sell Analysis Trendline Analysis Investment Advisor Options Advisor Options Chain & Analysis